Skip to main content
. 2012 Mar 2;344:e615. doi: 10.1136/bmj.e615

Table 2.

 List of interventions considered in cost effectiveness analysis of strategies to combat vision and hearing loss in WHO sub-Saharan African sub-region AfrE and South East Asian sub-region SearD

Intervention code Intervention description
Trachoma control
TRA-1 Mass treatment tetracycline ointment (50% coverage)
TRA-2 Mass treatment azithromycin (50% coverage)
TRA-3 Targeted treatment azithromycin (50% coverage)
TRA-4 Trichiasis surgery (50% coverage)
TRA-5 Mass treatment tetracycline ointment + trichiasis surgery (50% coverage)
TRA-6 Mass treatment azithromycin + trichiasis surgery (50% coverage)
TRA-7 Targeted treatment azithromycin + trichiasis surgery (50% coverage)
TRA-8 Mass treatment tetracycline ointment (80% coverage)
TRA-9 Mass treatment azithromycin (80% coverage)
TRA-10 Targeted treatment azithromycin (80% coverage)
TRA-11 Trichiasis surgery (80% coverage)
TRA-12 Mass treatment tetracycline ointment + trichiasis surgery (80% coverage)
TRA-13 Mass treatment azithromycin + trichiasis surgery (80% coverage)
TRA-14 Targeted treatment azithromycin + trichiasis surgery (80% coverage)
TRA-15 Mass treatment tetracycline ointment (95% coverage)
TRA-16 Mass treatment azithromycin (95% coverage)
TRA-17 Targeted treatment azithromycin (95% coverage)
TRA-18 Trichiasis surgery (95% coverage)
TRA-19 Mass treatment tetracycline ointment + trichiasis surgery (95% coverage)
TRA-20 Mass treatment azithromycin + trichiasis surgery (95% coverage)
TRA-21 Targeted treatment azithromycin + trichiasis surgery (95% coverage)
Cataract control
CAT-4 Extracapsular cataract extraction with posterior chamber lens implant (50% coverage)
CAT-5 Extracapsular cataract extraction with posterior chamber lens implant (80% coverage)
CAT-6 Extracapsular cataract extraction with posterior chamber lens implant (95% coverage)
Screening for hearing loss†
HEA-1 Annual screening primary school children (50% coverage)
HEA-2 Annual screening secondary school children (50% coverage)
HEA-3 Annual screening primary and secondary school children (50% coverage)
HEA-4 Screening adults every 5 years (50% coverage)
HEA-5 Screening adults every 10 years (50% coverage)
HEA-6 Passive screening all children and adults (50% coverage)
HEA-7 Annual screening primary school children + screening adults every 5 years (50% coverage)
HEA-8 Annual screening primary school children + screening adults every 10 years (50% coverage)
HEA-9 Annual screening secondary school children + screening adults every 5 years (50% coverage)
HEA-10 Annual screening secondary school children + screening adults every 10 years (50% coverage)
HEA-11 Annual screening primary and secondary school children + screening adults every 5 years (50% coverage)
HEA-12 Annual screening primary and secondary school children + screening adults every 10 years (50% coverage)
HEA-13 Annual screening primary school children (80% coverage)
HEA-14 Annual screening secondary school children (80% coverage)
HEA-15 Annual screening primary and secondary school children (80% coverage)
HEA-16 Screening adults every 5 years (80% coverage)
HEA-17 Screening adults every 10 years (80% coverage)
HEA-18 Passive screening all children and adults (80% coverage)
HEA-19 Annual screening primary school children + screening adults every 5 years (80% coverage)
HEA-20 Annual screening primary school children + screening adults every 10 years (80% coverage)
HEA-21 Annual screening secondary school children + screening adults every 5 years (80% coverage)
HEA-22 Annual screening secondary school children + screening adults every 10 years (80% coverage)
HEA-23 Annual screening primary and secondary school children + screening adults every 5 years (80% coverage)
HEA-24 Annual screening primary and secondary school children + screening adults every 10 years (80% coverage)
HEA-25 Annual screening primary school children (95% coverage)
HEA-26 Annual screening secondary school children (95% coverage)
HEA-27 Annual screening primary and secondary school children (95% coverage)
HEA-28 Screening adults every 5 years (95% coverage)
HEA-29 Screening adults every 10 years (95% coverage)
HEA-30 Passive screening all children and adults (95% coverage)
HEA-31 Annual screening primary school children + screening adults every 5 years (95% coverage)
HEA-32 Annual screening primary school children + screening adults every 10 years (95% coverage)
HEA-33 Annual screening secondary school children + screening adults every 5 years (95% coverage)
HEA-34 Annual screening secondary school children + screening adults every 10 years (95% coverage)
HEA-35 Annual screening primary and secondary school children + screening adults every 5 years (95% coverage)
HEA-36 Annual screening primary and secondary school children + screening adults every 10 years (95% coverage)
Meningitis
MEN-1 Ceftriaxione (50% coverage)
MEN-2 Ceftriaxione (80% coverage)
MEN-3 Ceftriaxione (95% coverage)
Chronic otitis media control
COM-1 Aural toilet (50% coverage)
COM-2 Topical antibiotics (50% coverage)
COM-3 Aural toilet (80% coverage)
COM-4 Topical antibiotics (80% coverage)
COM-5 Aural toilet (95% coverage)
COM-6 Topical antibiotics (95% coverage)
Uncorrected refractive error‡
RE-1 Annual screening all primary school children (50% coverage)
RE-2 Annual screening all secondary school children (50% coverage)
RE-3 Annual screening all primary and secondary school children (50% coverage)
RE-4 Annual screening children 8 years old (50% coverage)
RE-5 Annual screening children 13 years old (50% coverage)
RE-6 Annual screening children 8 and 13 years old (50% coverage)
RE-7 Annual screening all primary school children (80% coverage)
RE-8 Annual screening all secondary school children (80% coverage)
RE-9 Annual screening all primary and secondary school children (80% coverage)
RE-10 Annual screening children 8 years old (80% coverage)
RE-11 Annual screening children 13 years old (80% coverage)
RE-12 Annual screening children 8 and 13 years old (80% coverage)
RE-13 Annual screening all primary school children (95% coverage)
RE-14 Annual screening all secondary school children (95% coverage)
RE-15 Annual screening all primary and secondary school children (95% coverage)
RE-16 Annual screening children 8 years old (95% coverage)
RE-17 Annual screening children 13 years old (95% coverage)
RE-18 Annual screening children 8 and 13 years old (95% coverage)

*Coverage level relates to the geographic coverage of these eligible for intervention.

†Screening for hearing loss is in combination with the provision of hearing aids to those who need it.

‡Screening for uncorrected refractive error is in combination with the provision of spectacles to those who need it.